Stay updated with breaking news from Nasdaq Sxtp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP – Get Free Report) was the target of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 130,700 shares, a growth of 95.1% from the March 31st total of 67,000 shares. Currently, 1.5% of the shares of the company […]
60 Degrees Pharma (Nasdaq: SXTP) will sponsor a study using tafenoquine, an FDA-approved malaria drug, to treat canine babesiosis, a tick-borne disease....
60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP – Get Free Report) was the target of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 65,500 shares, a decline of 56.9% from the February 29th total of 152,000 shares. Approximately 1.5% of the company’s shares are short […]
60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP – Free Report) – HC Wainwright issued their Q1 2024 earnings estimates for shares of 60 Degrees Pharmaceuticals in a report issued on Friday, February 2nd. HC Wainwright analyst E. White forecasts that the company will earn ($0.17) per share for the quarter. HC Wainwright currently has a “Neutral” rating […]
60 Degrees Pharma Suspends Phase IIB COVID Study, Pivots to Commercialization of Treatments for Malaria and Tick-borne Illness...